|
JP4421894B2
(ja)
*
|
2001-07-20 |
2010-02-24 |
アブソーバー アクチボラゲット |
血液型抗原融合ポリペプチドおよびその使用方法
|
|
AU2003228067B2
(en)
*
|
2002-04-22 |
2008-05-29 |
Recopharma Ab |
Mucin fusion polypeptide vaccines, compositions and methods of use thereof
|
|
AU2003233008B2
(en)
*
|
2002-04-22 |
2008-04-24 |
Recopharma Ab |
Fusion polypeptides and methods for inhibiting microbial adhesion
|
|
AU2003249641B2
(en)
|
2002-05-16 |
2009-08-20 |
Glycomimetics, Inc. |
Compounds and methods for inhibiting selectin-mediated function
|
|
JP2006502986A
(ja)
*
|
2002-07-03 |
2006-01-26 |
グリコミメティクス， インコーポレイテッド |
新脈管形成に関与する医学的状態の診断および治療のための組成物および方法
|
|
EP1534748A2
(en)
*
|
2002-08-09 |
2005-06-01 |
Recopharma AB |
Fusion proteins and methods of producing same
|
|
US20050076759A1
(en)
*
|
2003-10-08 |
2005-04-14 |
Brian Westfall |
Linear saw with stab-cut bevel capability
|
|
US20040219158A1
(en)
*
|
2003-05-02 |
2004-11-04 |
Glycomimetics, Inc. |
Compositions and methods for diagnosis and therapy of medical conditions involving infection with pseudomonas bacteria
|
|
US7459523B2
(en)
*
|
2003-11-12 |
2008-12-02 |
Wisconsin Alumni Research Foundation |
Equine P-selectin glycoprotein ligand-1 and uses thereof
|
|
EP1685145A2
(en)
*
|
2003-11-19 |
2006-08-02 |
GlycoMimetics, Inc. |
Glycomimetic antagonists for both e- and p-selectins
|
|
US7361644B2
(en)
*
|
2003-11-19 |
2008-04-22 |
Glycomimetics, Inc. |
Specific antagonist for both E- and P-selectins
|
|
EP1782838A4
(en)
*
|
2004-06-23 |
2007-08-01 |
Japan Science & Tech Agency |
INHIBITION OF INFILTRATION AND CELL-COOLING MEDIUM
|
|
US8201377B2
(en)
*
|
2004-11-05 |
2012-06-19 |
Faus Group, Inc. |
Flooring system having multiple alignment points
|
|
WO2006127906A1
(en)
*
|
2005-05-25 |
2006-11-30 |
Glycomimetics, Inc. |
Heterobifunctional compounds for selectin inhibition
|
|
JP5175190B2
(ja)
*
|
2005-08-09 |
2013-04-03 |
グリコミメティクス， インコーポレイテッド |
シュードモナス由来のｐａ−ｉｌレクチン、ｐａ−ｉｉｌレクチンまたは両方のレクチンのグリコミメティック阻害剤
|
|
US7728117B2
(en)
|
2005-09-02 |
2010-06-01 |
Glycomimetics, Inc. |
Heterobifunctional pan-selectin inhibitors
|
|
WO2007033221A2
(en)
*
|
2005-09-13 |
2007-03-22 |
The General Hospital Corporation |
Methods and compositions for inhibition of immune responses
|
|
EP2264061A1
(en)
*
|
2006-01-26 |
2010-12-22 |
Recopharma AB |
Compositions and methods for inhibiting viral adhesion
|
|
US20070178447A1
(en)
*
|
2006-01-31 |
2007-08-02 |
Bethyl Laboratories, Inc. |
Method for decreasing interference in results of immunochemical methods
|
|
US20090176717A1
(en)
*
|
2006-06-01 |
2009-07-09 |
Glycomimetics, Inc. |
Galactosides and thiodigalactosides as inhibitors of pa-il lectin from pseudomonas
|
|
EP2074132B1
(en)
|
2006-10-12 |
2013-05-15 |
GlycoMimetics, Inc. |
Glycomimetic replacements for hexoses and n-acetyl hexosamines
|
|
US7998486B2
(en)
|
2006-10-25 |
2011-08-16 |
Newlink Genetics Corporation |
Enhanced immunogenicity of tumor associated antigens by addition of alphaGal epitopes
|
|
EP2457573A1
(en)
*
|
2007-02-09 |
2012-05-30 |
GlycoMimetics, Inc. |
Methods of use of glycomimetics with replacements for hexoses and N-Acetyl hexosamines
|
|
US8039442B2
(en)
*
|
2007-07-18 |
2011-10-18 |
Glycomimetics, Inc. |
Compounds and methods for treatment of sickle cell disease or complications associated therewith
|
|
WO2009126556A1
(en)
*
|
2008-04-08 |
2009-10-15 |
Glycomimetics, Inc. |
Pan-selectin inhibitor with enhanced pharmacokinetic activity
|
|
CA2727788A1
(en)
*
|
2008-06-13 |
2009-12-17 |
Glycomimetics, Inc. |
Treatment of cancers of the blood using selected glycomimetic compounds
|
|
US8410066B2
(en)
|
2009-05-01 |
2013-04-02 |
Glycomimetics, Inc. |
Heterobifunctional inhibitors of E-selectins and CXCR4 chemokine receptors
|
|
US9420770B2
(en)
|
2009-12-01 |
2016-08-23 |
Indiana University Research & Technology Corporation |
Methods of modulating thrombocytopenia and modified transgenic pigs
|
|
US8921328B2
(en)
|
2010-09-14 |
2014-12-30 |
Glycomimetics, Inc. |
E-selectin antagonists
|
|
AU2011347237A1
(en)
*
|
2010-12-21 |
2013-07-11 |
Recopharma Ab |
Tear substitutes
|
|
SI2794626T1
(en)
|
2011-12-22 |
2018-02-28 |
Glycomimetics, Inc. |
E-SELECTINE ANTAGONIST COMPOUNDS
|
|
LT2928476T
(lt)
|
2012-12-07 |
2018-05-25 |
Glycomimetics, Inc. |
Junginiai, kompozicijos ir būdai, naudojant e-selektino antagonistus, hemopoetinių ląstelių mobilizacijai
|
|
HUE045542T2
(hu)
|
2014-12-03 |
2019-12-30 |
Glycomimetics Inc |
E-szelektinek és CXCR4 kemokin receptorok heterobifunkcionális inhibitorai
|
|
WO2017127422A1
(en)
|
2016-01-22 |
2017-07-27 |
Glycomimetics, Inc. |
Glycomimetic inhibitors of pa-il and pa-iil lectins
|
|
WO2017151708A1
(en)
|
2016-03-02 |
2017-09-08 |
Glycomimetics, Inc. |
Methods for the treatment and/or prevention of cardiovescular disease by inhibition of e-selectin
|
|
EP3497131B1
(en)
|
2016-08-08 |
2022-03-09 |
GlycoMimetics, Inc. |
Combination of t-cell checkpoint inhibitors with inhibitors of e-selectin or cxcr4, or with heterobifunctional inhibitors of both e-selectin and cxcr4.
|
|
CA3037850A1
(en)
|
2016-10-07 |
2018-04-12 |
Glycomimetics, Inc. |
Highly potent multimeric e-selectin antagonists
|
|
CA3054605A1
(en)
|
2017-03-15 |
2018-09-20 |
Glycomimetics, Inc. |
Galactopyranosyl-cyclohexyl derivatives as e-selectin antagonists
|
|
EP3717013A1
(en)
|
2017-11-30 |
2020-10-07 |
GlycoMimetics, Inc. |
Methods of mobilizing marrow infiltrating lymphocytes and uses thereof
|
|
EP3732186A1
(en)
|
2017-12-29 |
2020-11-04 |
GlycoMimetics, Inc. |
Heterobifunctional inhibitors of e-selectin and galectin-3
|
|
US11707474B2
(en)
|
2018-03-05 |
2023-07-25 |
Glycomimetics, Inc. |
Methods for treating acute myeloid leukemia and related conditions
|
|
US20210260250A1
(en)
*
|
2018-06-12 |
2021-08-26 |
Rush University Medical Center |
Methods for Enhanced Endothelialization of Implanted Material
|
|
US11845771B2
(en)
|
2018-12-27 |
2023-12-19 |
Glycomimetics, Inc. |
Heterobifunctional inhibitors of E-selectin and galectin-3
|